Literature DB >> 3973412

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

B J McMahon, W L Alward, D B Hall, W L Heyward, T R Bender, D P Francis, J E Maynard.   

Abstract

Yupik Eskimos of southwestern Alaska have the highest known prevalence of hepatitis B virus infection of any general population in the United States. Prospective serological surveys of 1,280 seronegative Yupik Eskimos, performed between 1971 and 1976, identified 189 (14.8%) who developed serological evidence of hepatitis B virus infection. Twenty-six (13.8%) developed clinical hepatitis during the interval when seroconversion occurred. The proportion of patients with clinically apparent hepatitis increased with age (P less than .01), ranging from 9.5% of infections in patients who were four years of age or less to 33.3% of infections in patients who were 30 years of age or older. Twenty-five (13.3%) of the 188 individuals who were studied became chronic carriers of hepatitis B surface antigen. The risk of becoming a carrier was inversely related to the age of the patient at the time of infection (P = .02). Among patients who were four years of age or less when infected, 28.8% became chronic carriers of hepatitis B, as compared with 7.7% of those who were 30 years of age or older.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973412     DOI: 10.1093/infdis/151.4.599

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  164 in total

1.  Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.

Authors:  Hui-Fang Hung; Hsiu-Hsi Chen
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

2.  Clinical update: hepatitis B.

Authors:  Tram T Tran
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

3.  Optimal control for an age-structured model for the transmission of hepatitis B.

Authors:  Ramses Djidjou Demasse; Jean-Jules Tewa; Samuel Bowong; Yves Emvudu
Journal:  J Math Biol       Date:  2015-12-16       Impact factor: 2.259

4.  HBV Infection Among HIV-Infected Cohort and HIV-Negative Hospital Attendees in South Western Nigeria.

Authors:  Moses Olubusuyi Adewumi; Emmanuel Donbraye; Waidi Folorunso Sule; Olaniran Olarinde
Journal:  Afr J Infect Dis       Date:  2015

5.  Epidemiology of hepatitis C viral infection in Faisalabad, Pakistan: a retrospective study (2010-2012).

Authors:  Muhammad Arif Maan; Fatma Hussain; Muhammad Jamil
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

6.  HIV and Hepatitis B coinfection among perinatally HIV-infected Thai adolescents.

Authors:  Linda Aurpibul; Pagakrong Lumbiganon; Pope Kolasaraksa; Rawiwan Hansudewechakul; Pattaratida Sa-Nguanmoo; Pawinee Taeprasert; Torsak Bunupuradah; Yong Poovorawan; Virat Sirisanthana; Thanyawee Puthanakit
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

7.  Epidemiology of hepatitis B virus infection in Albania.

Authors:  Bashkim Resuli; Skerdi Prifti; Bledar Kraja; Tatjana Nurka; Mimoza Basho; Edita Sadiku
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 8.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

9.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.

Authors:  G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

10.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.